Humacyte's CEO demonstrates the bioengineered human arteries the company has developed and that is in front of FDA with an August decision date for its BLA

blonca9
May 22, 2024
1 min read

Laura Niklason shows us what Humacyte's Human Acellular Vessel (HAV) looks like, describes how it is manufactured, explains its utility, and gives an overview of other pipeline programs.

Recent Posts

See All

London based Baseimmune shows BiotechTV the new space it moved into in LBIC's Apex Building in Kings Cross where it will use its AI platform to discover and develop new vaccines

London based Laverock Therapeutics shows BiotechTV the new space it moved into in LBIC's Apex Building in Kings Cross where it will be doing its work on programmable gene silencing

The London BioScience Innovation Centre (LBIC) today launched its new Apex Building lab space facility for biotech companies in the heart of the Kings Cross Knowledge Quarter

Humacyte's CEO demonstrates the bioengineered human arteries the company has developed and that is in front of FDA with an August decision date for its BLA

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight